InstaMed NAD+ Strips: The Sublingual Longevity Option

Short answer: InstaMed NAD+ (Energy) is an orange-flavored dissolving strip with 100 mg of NAD+ per strip, 30 per box — in stock and publicly priced at $118 per 30-strip box. The sublingual route for NAD+ is genuinely promising, and early company-sponsored data on a comparable wafer format showed real blood-NAD+ movement.

If you've done the compound research, this article is about the product itself: what's on the label, what it costs where pricing is genuinely public, what the documentation shows, and what the sublingual NAD+ evidence actually consists of. For the molecule and the delivery science, the NAD+ pillar has the long version. For how strip NAD+ stacks up against IV, see sublingual NAD+ vs IV.

What you get in the box

InstaMed Pharmaceuticals (Salt Lake City/Draper, Utah) makes its peptides and NAD+ as thin oral dissolving films instead of injections or capsules. Energy is its NAD+ entry and one of the line's currently stocked retail SKUs. Straight off the Supplement Facts panel:

The film base matches the rest of the line: pullulan and β-cyclodextrin with glycerin and lecithin, plus flavor and color components. One strip on the tongue, let it dissolve, done. No refrigeration, no reconstitution, no measuring, no clinic appointment. Thirty strips per box also makes this the line's most generous count — a full month at the implied one-strip-daily cadence [brand claim — unverified].

Why NAD+ is the molecule that makes a strip interesting

Here's the elegant part. Intact NAD+ is a large, charged molecule (~663 Da) that doesn't survive the gut — swallow it in a capsule and it breaks down before reaching blood. That's why the NAD+ world runs on precursors like NMN and NR, which absorb fine orally and reliably raise blood NAD+ in human trials. But those are precursors — your body still has to convert them. A sublingual strip is the one consumer format that attempts to deliver NAD+ itself, directly, through the thin vascular tissue of the mouth. InstaMed describes its approach as "mouth to body delivery" [brand claim — unverified], and the rationale is real physiology, not marketing poetry.

The early signal is genuinely encouraging

The most direct research in this space comes from iX Biopharma, a Singapore-listed specialty pharma company working on a sublingual NAD+ wafer. Its announced results: a rat pharmacokinetic study (September 2, 2024; 18 Sprague-Dawley rats, LC-MS/MS) showing a roughly 2-fold peak in plasma NAD+ within 10 minutes of sublingual dosing [preclinical evidence], and a human pilot (July 9, 2024; nine healthy subjects, open-label and company-sponsored) reporting average whole-blood NAD+ up +59% at two weeks and +76% at six weeks [published human data — company pilot, n=9, uncontrolled]. A second-generation 100 mg wafer — the same per-unit strength as InstaMed's strip — followed.

Meanwhile, NAD+ biology itself is one of the best-explored areas in healthy-aging research, and interest in restoring declining NAD+ levels keeps growing across both academic and consumer channels. Many users of sublingual NAD+ products report noticing a difference in daily energy and morning readiness within the first couple of weeks — attributed, unquantified, and worth what anecdote is worth, but a consistent pattern across the category.

What it costs

NAD+ is not price-gated. The 30-strip box retails openly at $118. Prices change, so confirm the live figure on the NAD+ sublingual strips product page rather than trusting any article, including this one. For context, clinic NAD+ IV sessions commonly run into the hundreds of dollars per session — a comparison of delivery routes and price structures, not of effects.

The honest context, once

Two disclosures belong in any fair account of this product. First, the iX Biopharma signal is early and company-run: nine people, no placebo arm, a wafer rather than a pullulan strip, and no peer review — promising, not proven. Second, the NAD+ COA on file has a specific gap: it goes straight from appearance to heavy metals and microbials with no potency table, so the labeled 100 mg per strip is not independently verified by that document, and its flavor description conflicts with the label. Our standing advice is direct: ask the seller about lot-specific potency documentation before purchase. A COA that verifies "clean" but not "contains the labeled amount" answers half the question.

Who this product fits

Energy makes sense for the NAD+-curious buyer who wants direct NAD+ rather than a precursor, hates needles, and values a pre-dosed strip that travels in a wallet. It is not for anyone under 18, pregnant, or nursing; not for anyone unwilling to raise it with a licensed healthcare provider first; and not for anyone who requires verified potency documentation — until the COA gap closes, that buyer should ask questions before ordering.

The bottom line

InstaMed NAD+ is a well-specified, in-stock, publicly priced entry in the most scientifically interesting corner of the strip category: 100 mg per strip, 30 per box, orange flavor, $118 per 30-strip box. NAD+ is the rare case where the sublingual format has a genuine mechanistic argument and real early data pointing the right direction. Go in with the documentation question asked and answered, and this is one of the more compelling products in the line.

---

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.